BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32005583)

  • 21. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).
    Matz M; Coleman MP; Carreira H; Salmerón D; Chirlaque MD; Allemani C;
    Gynecol Oncol; 2017 Feb; 144(2):396-404. PubMed ID: 27919574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International variation in childhood cancer mortality rates from 2001 to 2015: Comparison of trends in the International Cancer Benchmarking Partnership countries.
    Smith L; Stiller CA; Aitken JF; Hjalgrim LL; Johannesen T; Lahteenmaki P; McCabe MG; Phillips R; Pritchard-Jones K; Steliarova-Foucher E; Winther JF; Woods RR; Glaser AW; Feltbower RG
    Int J Cancer; 2022 Jan; 150(1):28-37. PubMed ID: 34449879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
    Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
    BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
    O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
    J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.
    Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Miller C; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
    BMJ Open; 2019 Feb; 9(2):e024036. PubMed ID: 30782891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.
    Faber MT; Horsbøl TA; Baandrup L; Dalton SO; Kjaer SK
    Gynecol Oncol; 2022 Jan; 164(1):98-104. PubMed ID: 34763941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Stewart SL; Harewood R; Matz M; Rim SH; Sabatino SA; Ward KC; Weir HK
    Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5138-5159. PubMed ID: 29205312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
    Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
    Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer.
    Elzakkers JCJ; van der Aa MA; van Altena AM; de Hullu JA; Harmsen MG
    Gynecol Oncol; 2019 Nov; 155(2):213-219. PubMed ID: 31477282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data.
    Irodi A; Rye T; Herbert K; Churchman M; Bartos C; Mackean M; Nussey F; Herrington CS; Gourley C; Hollis RL
    BJOG; 2020 Oct; 127(11):1409-1420. PubMed ID: 32285600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.
    Ojamaa K; Veerus P; Baburin A; Everaus H; Innos K
    Int J Gynecol Cancer; 2017 Jan; 27(1):44-49. PubMed ID: 27870707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in colorectal cancer incidence in seven high-income countries: a population-based study.
    Araghi M; Soerjomataram I; Bardot A; Ferlay J; Cabasag CJ; Morrison DS; De P; Tervonen H; Walsh PM; Bucher O; Engholm G; Jackson C; McClure C; Woods RR; Saint-Jacques N; Morgan E; Ransom D; Thursfield V; Møller B; Leonfellner S; Guren MG; Bray F; Arnold M
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):511-518. PubMed ID: 31105047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
    Hannibal CG; Cortes R; Engholm G; Kjaer SK
    Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
    Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
    J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study.
    Ekmann-Gade AW; Høgdall CK; Seibæk L; Noer MC; Fagö-Olsen CL; Schnack TH
    Gynecol Oncol; 2022 Jan; 164(1):120-128. PubMed ID: 34716025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.
    Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK
    Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
    Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ
    Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.